Chan Gerald 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Common Stock
2022-01-01+4,230→ 4,230 total - Award
Stock Option (Right to Buy)
2022-01-01+8,554→ 8,554 totalExercise: $47.28Exp: 2029-12-31→ Common Stock (8,554 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit grant made on 1/1/2022 that fully vest on the first anniversary of the date of grant, subject to continued service as a director.
- [F2]This represents a non-qualified stock option grant made on 1/1/2022 that vests quarterly over 1 year from the date of grant, subject to continued service as a director, and expires seven years from the date of grant.